![](/img/cover-not-exists.png)
PCN52 HEALTH CARE COSTS ASSOCIATED WITH MULTIKINASE INHIBITORS (MKIS) FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) IN A CLINICAL PRACTICE SETTING IN ITALY
C Paglino, C Porta, C Canipari, L Antràs, K Chen, S Whittemore, A Luka, P Ramamurthy, MP Neary, MS DuhVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72141-0
File:
PDF, 81 KB
english, 2010